Invesco Ltd. Hille Vax, Inc. Transaction History

Invesco Ltd.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$11.59 - $16.7 $138,071 - $198,947	11,913 New	11,913 $160,000
Q4 2022 Feb 13, 2023	SELL	$13.52 - $21.46 $731,580 - $1.16 Million	-54,111 Reduced 76.1%	16,996 $284,000
Q3 2022 Nov 14, 2022	BUY	$10.5 - $22.01 $746,623 - $1.57 Million	71,107 New	71,107 $1.22 Million

40.5M

Ticker HLVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,427,200
Market Cap $58.8M
Description
HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.